Summary And Conclusions

Despite intensified metabolic control and antihypertensive treatment of diabetic patients, the development of diabetic nephropathy remains a serious problem. There is increasing evidence for a multifactorial pathogenesis of diabetic kidney disease, including various growth factors and cytokines as active players. This article has reviewed recent evidence for the significance of GH and VEGF in the development of experimental diabetic kidney disease. In addition, experimental data strongly suggest that GH and VEGF blockade may present new concepts in the treatment of diabetic renal complications. Future studies are warranted to fully characterize the clinical potential of GH and VEGF inhibitors as drugs for treatment of diabetic complications in general. Recent observations have suggested that there most likely in an important interaction or cross-talk among various growth factors that may promote the development of diabetic kidney disease. This would imply that strategies which involve multiple effects on the development of diabetic kidney disease may be more effective than drugs which influence one pathway. An increasing number of studies on the effects of combination of inhibitors with different points of action have the potential to provide new therapeutic strategies and experimental and clinical studies on combination therapies are expected to appear in the coming years.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook


Post a comment